Early research (Phase 1)Looking for participantsNCT05526924
What this trial is testing
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+2 more
University of Chicago 30